MEN1 — MultiTargetDB

Summary

KEGG Pathways (2)

Associated Diseases (10)

Top Co-occurrence Targets

InChIKey	pChEMBL	Type	Targets	Clinical
`QILXUBJKJXLPJR`	7.6	IC50	2	—
`VBGQYGIEWLSBGY`	7.6	IC50	2	—
`PRXLULUYVGAUHN`	7.6	IC50	2	—
`QFXSVAILBORUFA`	7.6	IC50	2	—
`SGSKCUULBFTJTH`	7.6	IC50	2	—
`IHHNJHMFVHNJBO`	7.5	IC50	2	—
`GVUFUZRLWIDDCW`	7.5	IC50	2	—
`JGYZPBXCLTVSLG`	7.5	IC50	2	—
`ZOQGZCVBPRNBEP`	7.5	IC50	2	—
`CMCOXPIPJRDLJR`	7.4	IC50	2	—
`FGZYNEBIPONAFQ`	7.4	IC50	2	—
`KCTFIWDZXROTJT`	7.4	IC50	2	—
`QXVQPHOTRMOPJS`	7.4	IC50	2	—
`YRNWQOLFUAOQEK`	7.4	IC50	2	—
`NAQAQSQPMQDCCJ`	7.4	IC50	2	—
`PYVSJMIULSNDBE`	7.4	IC50	2	—
`QXVQPHOTRMOPJS`	7.4	IC50	2	—
`KCTFIWDZXROTJT`	7.4	IC50	2	—
`UETJRHPTKZEBKL`	7.4	IC50	2	—
`KCTFIWDZXROTJT`	7.3	IC50	2	—
`SFDROHXKTATJBI`	7.3	IC50	2	—
`BAOZMBPXQIZDNW`	7.3	IC50	2	—
`TUAVWTQJOHDGIF`	7.3	IC50	2	—
`VJMSEJCFUWKXQR`	7.3	IC50	2	—
`IOXMNCZSIBUWBK`	7.2	IC50	2	—
`AKMXHRWRBGESKY`	7.2	IC50	2	—
`BGABNIUBTFNMNB`	7.2	IC50	2	—
`KAVBMCHFVYVUGP`	7.2	IC50	2	—
`ZCUAKOZUNBGFHR`	7.2	IC50	2	—
`ROBJDFLYWHJESD`	7.1	IC50	2	—
`FQHLCCRHERJGGU`	7.1	IC50	2	—
`UBUIDPURYFKDTJ`	7.1	IC50	2	—
`HOWWOQQFNUIEDX`	7.0	IC50	2	—
`PAQXRXLELGMMTP`	7.0	IC50	2	—
`GPUCGUREPBUUPX`	7.0	IC50	2	—
`WXYILIFTWPRGQC`	7.0	IC50	2	—
`KUBSRASLWYNRKJ`	7.0	IC50	2	—
`TVPHEUCQQXAPKZ`	7.0	IC50	2	—
`XIJLQIRAWOEATH`	7.0	IC50	2	—
`FDPSNDOCRPXFCD`	7.0	IC50	2	—
`GRCIWJRXZFZJCZ`	7.0	IC50	2	—
`NQXVDDGKDJESCO`	6.9	IC50	2	—
`GIWCILLVZIEDKV`	6.9	IC50	2	—
`QDJNCNNOOZJAPQ`	6.9	IC50	2	—
`ZZVXSOZWKGNLLE`	6.9	IC50	2	—
`FDLXLYIFHPVTGM`	6.9	IC50	2	—
`VCGGKAFSZXGDJK`	6.9	IC50	2	—
`PRFGRQZQIVZYDV`	6.8	IC50	2	—
`ZXKYRAQRTUGVRY`	6.8	IC50	2	—
`XNLFOGWQUFHWMA`	6.8	IC50	2	—